Amarantus Bioscience Holdings Inc (AMBS)

[Inoviorulez]

There is no doubt that investors are disgruntled which is why they are voicing their opinion. They are painting the truth and the truth is that nothing is rosy here. ESS is a dermatological product that has been passed on by other companies. If it was so great why did no other big pharma or other company pony up big money for it. It was bought on the cheap so Gerald could keep his paycheck and keep his dilution machine running.

They bought it for a measly $2.5 million. If it was so great it would have been worth much more.

"As required under the Agreement, Amarantus made the final payments due to Regenicin in the amount of $2.3 Million, along with a payment of $200,000 to Regenicin's senior secured creditor. In addition, Regenicin with Amarantus and Lonza Group, Ltd and its related entities, have signed a Settlement Agreement in the company's lawsuit with Lonza Group, Ltd and its related entities. Regenicin has filed a joint dismissal of all claims, known or unknown, in the Lonza matter."